DASATINIB |
202103 |
001 |
ANDA |
DASATINIB |
TABLET;ORAL |
20MG |
No
|
No
|
2016/06/10
|
2016/06/10
|
APOTEX |
Prescription |
DASATINIB |
202103 |
002 |
ANDA |
DASATINIB |
TABLET;ORAL |
50MG |
No
|
No
|
2016/06/10
|
2016/06/10
|
APOTEX |
Prescription |
DASATINIB |
202103 |
003 |
ANDA |
DASATINIB |
TABLET;ORAL |
70MG |
No
|
No
|
2016/06/10
|
2016/06/10
|
APOTEX |
Prescription |
DASATINIB |
202103 |
004 |
ANDA |
DASATINIB |
TABLET;ORAL |
100MG |
No
|
No
|
2016/06/10
|
2016/06/10
|
APOTEX |
Prescription |
DASATINIB |
203180 |
001 |
ANDA |
DASATINIB |
TABLET;ORAL |
80MG |
No
|
No
|
2021/11/23
|
2021/11/23
|
APOTEX |
Prescription |
DASATINIB |
203180 |
002 |
ANDA |
DASATINIB |
TABLET;ORAL |
140MG |
No
|
No
|
2021/11/23
|
2021/11/23
|
APOTEX |
Prescription |
DASATINIB |
216261 |
002 |
ANDA |
DASATINIB |
TABLET; ORAL |
50mg |
No
|
No
|
2022/06/09
(TA)
|
--
|
ALEMBIC PHARMS LTD |
None (Tentative Approval) |
DASATINIB |
216261 |
003 |
ANDA |
DASATINIB |
TABLET; ORAL |
70mg |
No
|
No
|
2022/06/09
(TA)
|
--
|
ALEMBIC PHARMS LTD |
None (Tentative Approval) |
DASATINIB |
216261 |
004 |
ANDA |
DASATINIB |
TABLET; ORAL |
80mg |
No
|
No
|
2022/06/09
(TA)
|
--
|
ALEMBIC PHARMS LTD |
None (Tentative Approval) |
DASATINIB |
216261 |
005 |
ANDA |
DASATINIB |
TABLET; ORAL |
100mg |
No
|
No
|
2022/06/09
(TA)
|
--
|
ALEMBIC PHARMS LTD |
None (Tentative Approval) |
DASATINIB |
216261 |
006 |
ANDA |
DASATINIB |
TABLET; ORAL |
140mg |
No
|
No
|
2022/06/09
(TA)
|
--
|
ALEMBIC PHARMS LTD |
None (Tentative Approval) |
DASATINIB |
214350 |
001 |
ANDA |
DASATINIB |
TABLET;ORAL |
20MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
214350 |
002 |
ANDA |
DASATINIB |
TABLET;ORAL |
50MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
214350 |
003 |
ANDA |
DASATINIB |
TABLET;ORAL |
70MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
214350 |
004 |
ANDA |
DASATINIB |
TABLET;ORAL |
80MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
214350 |
005 |
ANDA |
DASATINIB |
TABLET;ORAL |
100MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
214350 |
006 |
ANDA |
DASATINIB |
TABLET;ORAL |
140MG |
No
|
No
|
2022/08/22
(TA)
|
--
|
LUPIN |
None (Tentative Approval) |
DASATINIB |
211094 |
002 |
ANDA |
DASATINIB |
TABLET;ORAL |
50MG |
No
|
No
|
2023/12/06
(TA)
|
--
|
TEVA PHARMS USA INC |
None (Tentative Approval) |
DASATINIB |
211094 |
003 |
ANDA |
DASATINIB |
TABLET;ORAL |
70MG |
No
|
No
|
2023/12/06
(TA)
|
--
|
TEVA PHARMS USA INC |
None (Tentative Approval) |
DASATINIB |
211094 |
004 |
ANDA |
DASATINIB |
TABLET;ORAL |
80MG |
No
|
No
|
2023/12/06
(TA)
|
--
|
TEVA PHARMS USA INC |
None (Tentative Approval) |